153 related articles for article (PubMed ID: 36863694)
21. Colorectal cancer screening with odour material by canine scent detection.
Sonoda H; Kohnoe S; Yamazato T; Satoh Y; Morizono G; Shikata K; Morita M; Watanabe A; Morita M; Kakeji Y; Inoue F; Maehara Y
Gut; 2011 Jun; 60(6):814-9. PubMed ID: 21282130
[TBL] [Abstract][Full Text] [Related]
22. KRAS mutations and M2PK upregulation in stool samples from individuals with positive fecal occult blood tests screened for colorectal cancer.
Battaglia P; Baritono E; Remo A; Vendraminelli R; Conti A
Tumori; 2014; 100(2):122-7. PubMed ID: 24852854
[TBL] [Abstract][Full Text] [Related]
23. Early Detection of Colorectal Cancer: a Multi-Center Pre-Clinical Case Cohort Study for Validation of a Combined DNA Stool Test.
Dollinger MM; Behl S; Fleig WE
Clin Lab; 2018 Oct; 64(10):1719-1730. PubMed ID: 30336540
[TBL] [Abstract][Full Text] [Related]
24. Analysis of the effectiveness of two noninvasive fecal tests used to screen for colorectal cancer in average-risk adults.
Sharma T
Public Health; 2020 May; 182():70-76. PubMed ID: 32179290
[TBL] [Abstract][Full Text] [Related]
25. Novel Diagnostic Biomarkers in Colorectal Cancer.
Zygulska AL; Pierzchalski P
Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35055034
[TBL] [Abstract][Full Text] [Related]
26. A novel method for early detection of colorectal cancer based on detection of methylation of two fragments of syndecan-2 (SDC2) in stool DNA.
Ma L; Qin G; Gai F; Jiang Y; Huang Z; Yang H; Yao S; Du S; Cao Y
BMC Gastroenterol; 2022 Apr; 22(1):191. PubMed ID: 35436855
[TBL] [Abstract][Full Text] [Related]
27. Volatile organic compounds analysis as a potential novel screening tool for colorectal cancer: A systematic review and meta-analysis.
Zhou W; Tao J; Li J; Tao S
Medicine (Baltimore); 2020 Jul; 99(27):e20937. PubMed ID: 32629696
[TBL] [Abstract][Full Text] [Related]
28. Fecal occult blood test for colorectal cancer screening: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2009; 9(10):1-40. PubMed ID: 23074514
[TBL] [Abstract][Full Text] [Related]
29. Breath testing as potential colorectal cancer screening tool.
Amal H; Leja M; Funka K; Lasina I; Skapars R; Sivins A; Ancans G; Kikuste I; Vanags A; Tolmanis I; Kirsners A; Kupcinskas L; Haick H
Int J Cancer; 2016 Jan; 138(1):229-36. PubMed ID: 26212114
[TBL] [Abstract][Full Text] [Related]
30. Early detection of colorectal cancer: from conventional methods to novel biomarkers.
Vatandoost N; Ghanbari J; Mojaver M; Avan A; Ghayour-Mobarhan M; Nedaeinia R; Salehi R
J Cancer Res Clin Oncol; 2016 Feb; 142(2):341-51. PubMed ID: 25687380
[TBL] [Abstract][Full Text] [Related]
31. Urine as a biological modality for colorectal cancer detection.
Chandrapalan S; Arasaradnam RP
Expert Rev Mol Diagn; 2020 May; 20(5):489-496. PubMed ID: 32130868
[No Abstract] [Full Text] [Related]
32. Determination of volatile organic compounds in SW620 colorectal cancer cells and tumor-bearing mice.
Wang G; Li Y; Liu M; Guo N; Han C; Liu D; Li D; Yang M; Peng Y; Liu Y; Yu K; Wang C
J Pharm Biomed Anal; 2019 Apr; 167():30-37. PubMed ID: 30738241
[TBL] [Abstract][Full Text] [Related]
33. A New-Generation Fecal Immunochemical Test (FIT) Is Superior to Quaiac-based Test in Detecting Colorectal Neoplasia Among Colonoscopy Referral Patients.
Vasilyev S; Smirnova E; Popov D; Semenov A; Eklund C; Hendolin P; Paloheimo L; Syrjänen K
Anticancer Res; 2015 May; 35(5):2873-80. PubMed ID: 25964570
[TBL] [Abstract][Full Text] [Related]
34. Fresh vs Frozen Samples and Ambient Temperature Have Little Effect on Detection of Colorectal Cancer or Adenomas by a Fecal Immunochemical Test in a Colorectal Cancer Screening Cohort in Germany.
Chen H; Werner S; Brenner H
Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1547-1556.e5. PubMed ID: 27793749
[TBL] [Abstract][Full Text] [Related]
35. [Proton nuclear magnetic resonance spectroscopy recognition of metabolic patterns in fecal extracts for early diagnosis of colorectal cancer].
Lin Y; Wang ZN; Ma CC; Liu CK; Yang JR; Shen ZW; Wu RH
Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Sep; 50(9):788-793. PubMed ID: 27655598
[No Abstract] [Full Text] [Related]
36. Detection of colorectal cancer (CRC) by urinary volatile organic compound analysis.
Arasaradnam RP; McFarlane MJ; Ryan-Fisher C; Westenbrink E; Hodges P; Thomas MG; Chambers S; O'Connell N; Bailey C; Harmston C; Nwokolo CU; Bardhan KD; Covington JA
PLoS One; 2014; 9(9):e108750. PubMed ID: 25268885
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of Fecal M2PK as a Diagnostic Marker in Colorectal Cancer.
Dabbous HK; Mohamed YAE; El-Folly RF; El-Talkawy MD; Seddik HE; Johar D; Sarhan MA
J Gastrointest Cancer; 2019 Sep; 50(3):442-450. PubMed ID: 29626277
[TBL] [Abstract][Full Text] [Related]
38. Feasibility of quantifying
Oh TJ; Oh HI; Seo YY; Jeong D; Kim C; Kang HW; Han YD; Chung HC; Kim NK; An S
Clin Epigenetics; 2017; 9():126. PubMed ID: 29225717
[TBL] [Abstract][Full Text] [Related]
39. Non-coding RNAs as Biomarkers for Colorectal Cancer Screening and Early Detection.
Slaby O
Adv Exp Med Biol; 2016; 937():153-70. PubMed ID: 27573899
[TBL] [Abstract][Full Text] [Related]
40. Specificity of metabolic colorectal cancer biomarkers in serum through effect size.
Di Giovanni N; Meuwis MA; Louis E; Focant JF
Metabolomics; 2020 Aug; 16(8):88. PubMed ID: 32789702
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]